Nchi: Marekani
Lugha: Kiingereza
Chanzo: NLM (National Library of Medicine)
HUMAN IMMUNOGLOBULIN G (UNII: 66Y330CJHS) (HUMAN IMMUNOGLOBULIN G - UNII:66Y330CJHS)
Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.
HUMAN IMMUNOGLOBULIN G
HUMAN IMMUNOGLOBULIN G 50 mg in 1 mL
Intravenous
PRESCRIPTION DRUG
Octagam is an immune globulin intravenous (human) 5% liquid indicated for treatment of primary humoral immunodeficiency (PI), such as congenital agammaglobulinemia, common variable immunodeficiency, X-linked agammaglobulinemia, Wiskott-Aldrich syndrome and severe combined immunodeficiencies. Octagam 5% liquid is contraindicated in patients who have acute severe hypersensitivity reactions to human immunoglobulin. Octagam 5% liquid contains trace amounts of IgA (not more than 0.2 mg/ml in a 5% solution). It is contraindicated in IgA deficient patients with antibodies against IgA and history of hypersensitivity (See Description [11]). Octagam 5% liquid is contraindicated in patients with acute hypersensitivity reaction to corn. Octagam 5% liquid contains maltose, a disaccharide sugar which is derived from corn. Patients known to have corn allergies should avoid using Octagam 5% liquid. Pregnancy Category C. Animal reproduction studies have not been conducted with Octagam 5% liquid. It is also not known whether O
Biologic Licensing Application
OCTAGAM IMMUNE GLOBULIN (HUMAN)- IMMUNE GLOBULIN SOLUTION OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGESELLSCHAFT M.B.H. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION OCTAGAM, IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 5% LIQUID PREPARATION INITIAL U.S. APPROVAL: 2004 - THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE OCTAGAM, IMMUNE GLOBULIN INTRAVENOUS (HUMAN), SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR OCTAGAM. INDICATIONS AND USAGE •Octagam is an immune globulin intravenous (human), 5% liquid, indicated for treatment of primary humoral immunodeficiency (PI) (1). (1) DOSAGE AND ADMINISTRATION •Intravenous use only (2). (2) • (2) INDIC ATIO N DO SE INITIAL INFUSION RATE MAINTENANCE INFUSION RATE (IF TOLERATED) PI (2) 300-600mg/kg (2) 0.5mg/kg/min (2) 3.33 mg/kg/min (2) Every 3-4 weeks (2) •Ensure that patients with pre-existing renal insufficiency are not volume depleted; discontinue Octagam 5% liquid if renal function deteriorates (2.4). (2) •For patients at risk of renal dysfunction or thrombotic events, administer Octagam 5% liquid at the minimum infusion rate practicable (2.4). (2) DOSAGE FORMS AND STRENGTHS •Octagam 5% liquid is supplied in 1.0 g, 2.5 g, 5 g , 10 g or 25 g single use bottles (3, 16) (3) CONTRAINDICATIONS •Anaphylactic or severe systemic reactions to human immunoglobulin (4) (4) •IgA deficient patients with antibodies against IgA and a history of hypersensitivity (4) (4) •Patients with acute hypersensitivity reaction to corn (4) (4) WARNINGS AND PRECAUTIONS •IgA deficient patients with antibodies against IgA are at greater risk of developing severe hypersensitivity and anaphylactic reactions Epinephrine should be available immediately to treat any acute severe hypersensitivity reactions. (5.1) (5) •Monitor renal function, including blood urea nitrogen and serum creatinine, and urine output in patients at risk of developing acute renal failure. (5.2) (5) •Falsely elevated blood glucose readings may occur during and after the infusion of Octagam Soma hati kamili